Looking for a Job in Neurology?doi:10.1097/01.NT.0000991252.72416.07Lola ButcherWolters Kluwer Health, Inc.Neurology Today
In general, ongoing immunotherapy should not be stopped because of the COVID-19 pandemic; treatment initiation and optimization are also recommended. For some aspects of immunotherapy in the context of COVID-19, consensus in the literature is low, and collection of data in patient registries is ...